Session Information
Date: Sunday, November 5, 2017
Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: Vitamin D insufficiency/deficiency is common in SLE. In other populations, vitamin D has been associated with cardiovascular risk factors such as blood pressure and serum cholesterol. We assessed whether there was an association between serum vitamin D and total serum cholesterol in a large SLE cohort.
Methods: Serum 25-hydroxy vitamin D [25(OH)D] was measured at quarterly clinic visits in a large SLE cohort. 1358 different patients were observed from 1 to 40 visits (the median was 11). The patients were 92% female, 50% Caucasian, 41% African American. Age ranged from 17 to 89 years. When the 25(OH)D level was below 40 mg/ml, the patient was prescribed supplemental vitamin D, usually 50,000 IU weekly. We explored the association between serum vitamin D levels and serum cholesterol using longitudinal regression models.
Results: Levels of 25(OH)D below 50 ng/ml were associated with a higher mean cholesterol. There was a significantly negative linear relationship between vitamin D and mean cholesterol when 25(OH)D was below 50 ng/ml.
Table 1: Slope of Relationship Between 25(OH) Vitamin D and Mean Cholesterol Over Different Ranges of 25(OH) Vitamin D
Range of 25(OH) Vitamin D |
Estimated slope (95% Confidence Interval) |
|||
Unadjusted |
P-value |
Adjusted |
P-value |
|
0-50 ng/ml |
-0.37 (-0.42, -0.32) |
<0.0001 |
-0.30 (-0.35, -0.24) |
<0.0001 |
50+ ng/ml |
-0.09 (-0.15, -0.02) |
0.014 |
-0.11 (-0.18, -0.03) |
0.0037 |
1 Adjusted for age, age-squared, sex, race, proportion of time on hydroxychloroquine use, corticosteroid use, BMI and systolic blood pressure.
Conclusion: We observed a decline in total cholesterol as vitamin D increased to the normal range. Vitamin D supplementation significantly reduced cholesterol, even after adjustment for hydroxychloroquine. Vitamin D, like hydroxychloroquine, has benefit beyond immunomodulation, in that it reduces multiple cardiovascular risk factors.
To cite this abstract in AMA style:
Petri M, Goldman D, Magder LS. Vitamin D Deficiency Is Associated with Increased Serum Cholesterol Among Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/vitamin-d-deficiency-is-associated-with-increased-serum-cholesterol-among-patients-with-systemic-lupus-erythematosus/. Accessed .« Back to 2017 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/vitamin-d-deficiency-is-associated-with-increased-serum-cholesterol-among-patients-with-systemic-lupus-erythematosus/